EDA Chairman Decree Of year 2020-2021-2022
| About | Issue date | Decree Number |
|
Reorganizing The Health Requirements For Pharmaceutical Institutions |
13/09/2009 | (EDA Chairman Decree No. (380 For Year 2009 |
|
Arabic version |
14/04/2020 | (EDA Chairman Decree No. (4 ) Of Year 2020 |
|
Regarding The following rules concerning procedures of import and customs release of medical products (human pharmaceutical, biological, veterinary, herbal, and cosmetic products, as well as disinfectants and pesticides); raw materials (active, inactive); packing materials; other materials for analysis requirements and related chemicals are approved. |
25/08/2020 | EDA Chairman Decree No. (66) of 2020 |
|
regarding the rules in inspect of the medical products and devices export procedure subject to the provisions of Law No.( 151) of 2019 |
14/12/2020 | EDA Chairman Decree No. (216) of 2020 |
| EDA Chairman Decree Of year 2021 | ||
|
Arabic version |
07/02/2021 | EDA Chairman Decree No. (2) of 2021 |
|
regarding the work by Manufacturing for export System Shall be approved for each of medical products and devices |
07/02/2021 | EDA Chairman Decree No. (69) of 2021 |
|
, it is impermissible to establish medical products or devices factories, or adding new production lines to existing factories, except after being formally licensed by EDA |
25/02/2021 | (EDA Chairman Decree No. (99 For Year 2021 |
|
regarding to the travel of inspection committees from the Egyptian medicines Authority |
09/11/2021 | EDA Chairman Decree No.( 157) of 2021 |
| Regarding The Requirements that shall be met in The Accessory Stores Related to Pharmaceutical Institutions | 25/05/2021 | (EDA Chairman Decree No. (271 For Year 2021 |
|
Regarding the Regulation of Scientific Offices |
07/07/2021 | (EDA Chairman Decree No. (315 For Year 2021 |
|
Arabic version |
14/12/2020 | EDA Chairman Decree No. (340) of 2021 |
|
Concerning Issuing the Rules of Biological Products’ Registration Promulgating |
29/07/2021 | (EDA Chairman Decree No. (343 For Year 2021 |
|
Arabic version |
23/08/2021 | EDA Chairman Decree No. (394) of 2021 |
|
Arabic version |
12/09/2021 | EDA Chairman Decree No. (429) of 2021 |
|
Arabic version |
30/09/2021 | EDA Chairman Decree No. (442) of 2021 |
|
Arabic version |
03/10/2021 | EDA Chairman Decree No. (443) of 2021 |
|
Arabic version |
11/10/2021 | EDA Chairman Decree No. (444) of 2021 |
|
Arabic version |
29/11/2021 | EDA Chairman Decree No. (469) of 2021 |
|
Arabic version |
19/10/2021 | EDA Chairman Decree No. (480) of 2021 |
|
Arabic version |
19/10/2021 | EDA Chairman Decree No. (481) of 2021 |
|
Arabic version |
31/10/2021 | EDA Chairman Decree No. (499) of 2021 |
|
Arabic version |
31/10/2021 | EDA Chairman Decree No. (505) of 2021 |
|
Arabic version |
29/11/2021 | EDA Chairman Decree No. (585) of 2021 |
|
Arabic version |
2/12/2021 | EDA Chairman Decree No. (590) of 2021 |
|
Arabic version |
11/12/2021 | EDA Chairman Decree No. (605) of 2021 |
|
EDA Chairman Decree Of year 2022 |
||
|
Arabic version |
5/1/2022 | EDA Chairman Decree No. (3) of 2022 |
|
concerning replacement of the text of article four of the aforementioned Decree of the President of the Egyptian Drug Authority No. (343) of 2021 by the following text |
02/02/2022 | EDA Chairman Decree no.38 of 2022 |
|
Arabic version |
28/02/2022 | EDA Chairman Decree no.88 of 2022 |
|
Concerning Approving the Egyptian Guideline for Regulatory Procedures of Good oversight on Clinical Research Practices |
21/02/2022 | EDA Chairman Decree the No. (111) of year 2022 |
|
Arabic version |
26/02/2022 | EDA Chairman Decree the No. (119) Of year 2022 |
|
Arabic version |
26/02/2022 | EDA Chairman Decree the No. (120) Of year 2022 |
|
Arabic version |
26/02/2022 | EDA Chairman Decree the No. (121) Of year 2022 |
|
Arabic version |
27/02/2022 | EDA Chairman Decree the No. (122) Of year 2022 |
|
Arabic version |
28/02/2022 | EDA Chairman Decree the No. (125) Of year 2022 |
|
Inspection teams shall be formed, from the following names, for inspecting the research institutions and relevant entities which conduct the clinical medical research, in order to verify of |
02/03/2022 | EDA Chairman Decree the No. (136) Of year 2022 |
|
Arabic version |
07/03/2022 | EDA Chairman Decree the No. (146) Of year 2022 |
| Concerning Issuing the Rules of Biological Products’ Registration Promulgating | 14/03/2022 | EDA Chairman Decree the No. (150) Of year 2022 |
| 04/04/2022 | EDA Chairman Decree the No. (190) Of 2022 | |
| Arabic version | 12/05/2022 | EDA Chairman Decree the No. (272) Of year 2022 |
| Regarding the Enrolling of Proficiency Testing within the Mechanisms of Evaluating Good Laboratory Practices in the Quality Control laboratories the Factories of Pharmaceutical Companies |
12/05/2022 | EDA Chairman Decree No. (273) of 2022 |
| Regarding Accrediting the Quality Control of The Cosmetic Products | 09/06/2022 | EDA Chairman Decree No. (342) of 2022 |
| Arabic version | 08/06/2022 | EDA Chairman Decree No. (382) of 2022 |
| Arabic version | 18/07/2022 | EDA Chairman Decree No. (424) Of 2022 |
| the Policy and Rules Regulating the Batches of Biological Products Release President of Egyptian Drug Authority, |
18/07/2022 | EDA Chairman Decree No. (425) Of year 2022 |
| Arabic version | 25/07/2022 | EDA Chairman Decree No. (434) Of year 2022 |
| Arabic version | 01/09/2022 | EDA Chairman Decree No. (555) Of year 2022 |
|
Arabic version |
08/09/2022 | EDA Chairman Decree No. (572) Of year 2022 |
| This decree shall be implemented with respect to application of the principle of reliance on reference health authorities in the registration and laboratory testing of imported medical products for human use that have been granted a Certificate of Pharmaceutical Product from one of the reference countries approved by the Technical Committee for Drug Control. |
06/12/2022 | EDA Chairman Decree No. (780) of 2022 |
| Arabic version | 06/12/2022 | EDA Chairman Decree No. (781) of 2022 |
| Arabic version | 06/12/2022 | EDA Chairman Decree No. (783) of 2022 |
| Arabic version | 12/12/2022 | |